Literature DB >> 24629450

Design, synthesis and biological evaluation of a series of pyrano chalcone derivatives containing indole moiety as novel anti-tubulin agents.

Guangcheng Wang1, Chunyan Li1, Lin He1, Kai Lei1, Fang Wang1, Yuzi Pu1, Zhuang Yang2, Dong Cao1, Liang Ma1, Jinying Chen1, Yun Sang2, Xiaolin Liang1, Mingli Xiang1, Aihua Peng1, Yuquan Wei1, Lijuan Chen3.   

Abstract

A new series of pyrano chalcone derivatives containing indole moiety (3-42, 49a-49r) were synthesized and evaluated for their antiproliferative activities. Among all the compounds, compound 49b with a propionyloxy group at the 4-position of the left phenyl ring and N-methyl-5-indoly on the right ring displayed the most potent cytotoxic activity against all tested cancer cell lines including multidrug resistant phenotype, which inhibits cancer cell growth with IC50 values ranging from 0.22 to 1.80μM. Furthermore, 49b significantly induced cell cycle arrest in G2/M phase and inhibited the polymerization of tubulin. Molecular docking analysis demonstrated the interaction of 49b at the colchicine binding site of tubulin. In experiments in vivo, 49b exerted potent anticancer activity in HepG2 human liver carcinoma in BALB/c nude mice. These results indicated these compounds are promising inhibitors of tubulin polymerization for the potential treatment of cancer.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Chalcone; Indole; Millepachine; Tubulin

Mesh:

Substances:

Year:  2014        PMID: 24629450     DOI: 10.1016/j.bmc.2014.02.028

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  11 in total

Review 1.  Chalcone: A Privileged Structure in Medicinal Chemistry.

Authors:  Chunlin Zhuang; Wen Zhang; Chunquan Sheng; Wannian Zhang; Chengguo Xing; Zhenyuan Miao
Journal:  Chem Rev       Date:  2017-05-10       Impact factor: 60.622

2.  Novel synthetic chalcones induce apoptosis in the A549 non-small cell lung cancer cells harboring a KRAS mutation.

Authors:  Yiqiang Wang; Andreas Hedblom; Steffi K Koerner; Mailin Li; Finith E Jernigan; Barbara Wegiel; Lijun Sun
Journal:  Bioorg Med Chem Lett       Date:  2016-10-24       Impact factor: 2.823

Review 3.  Target-based anticancer indole derivatives and insight into structure‒activity relationship: A mechanistic review update (2018-2021).

Authors:  Ashima Dhiman; Rupam Sharma; Rajesh K Singh
Journal:  Acta Pharm Sin B       Date:  2022-04-01       Impact factor: 14.903

4.  Novel hybrids derived from aspirin and chalcones potently suppress colorectal cancer in vitro and in vivo.

Authors:  Shan Lu; Obinna N Obianom; Yong Ai
Journal:  Medchemcomm       Date:  2018-08-27       Impact factor: 3.597

5.  Synthesis and biological evaluation of alpha-bromoacryloylamido indolyl pyridinyl propenones as potent apoptotic inducers in human leukaemia cells.

Authors:  Romeo Romagnoli; Filippo Prencipe; Luisa Carlota Lopez-Cara; Paola Oliva; Stefania Baraldi; Pier Giovanni Baraldi; Francisco Estévez-Sarmiento; José Quintana; Francisco Estévez
Journal:  J Enzyme Inhib Med Chem       Date:  2018-12       Impact factor: 5.051

6.  An Isoxazole Chalcone Derivative Enhances Melanogenesis in B16 Melanoma Cells via the Akt/GSK3β/β-Catenin Signaling Pathways.

Authors:  Li Yin; Chao Niu; Li-Xin Liao; Jun Dou; Maidina Habasi; Haji Akber Aisa
Journal:  Molecules       Date:  2017-11-28       Impact factor: 4.411

7.  Synthesis, biological evaluation, and molecular modelling of new naphthalene-chalcone derivatives as potential anticancer agents on MCF-7 breast cancer cells by targeting tubulin colchicine binding site.

Authors:  Guangcheng Wang; Wenjing Liu; Zipeng Gong; Yong Huang; Yongjun Li; Zhiyun Peng
Journal:  J Enzyme Inhib Med Chem       Date:  2020-12       Impact factor: 5.051

Review 8.  A review on synthetic chalcone derivatives as tubulin polymerisation inhibitors.

Authors:  Wenjing Liu; Min He; Yongjun Li; Zhiyun Peng; Guangcheng Wang
Journal:  J Enzyme Inhib Med Chem       Date:  2022-12       Impact factor: 5.051

9.  Diverse Molecular Targets for Chalcones with Varied Bioactivities.

Authors:  Bo Zhou; Chengguo Xing
Journal:  Med Chem (Los Angeles)       Date:  2015-08-22

Review 10.  Chalcone Scaffold in Anticancer Armamentarium: A Molecular Insight.

Authors:  Manik Das; Kuntal Manna
Journal:  J Toxicol       Date:  2016-01-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.